Bridgefront Capital »

Catalyst Pharmaceutical Partners shares owned by Bridgefront Capital

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Bridgefront Capital from 13F filings

Historical chart of Bridgefront Capital investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Bridgefront Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Bridgefront Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $555k 22k 24.76
2023-03-31 $171k 10k 16.58
2022-12-31 $321k 17k 18.60
2021-06-30 $158k 28k 5.75
2021-03-31 $95k 21k 4.61

More positions owned by Bridgefront Capital

Take-Two Interactive Software (TTWO)
TPG Com Cl A (TPG)
Constellation Brands Cl A (STZ)
Broadcom (AVGO)
Encana Corporation (OVV)
Kimberly-Clark Corporation (KMB)
Clorox Company (CLX)
Lamb Weston Hldgs (LW)
Keysight Technologies (KEYS)
EQT Corporation (EQT)
Celsius Hldgs Com New (CELH)
Amgen (AMGN)
Micron Technology (MU)
Host Hotels & Resorts (HST)
Agree Realty Corporation (ADC)

View all positions for Bridgefront Capital

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
Vanguard Capital Management
American Century Companies
Deerfield Management Company
Dimensional Fund Advisors
Bank of America Corporation
Geode Capital Management
Morgan Stanley
Vanguard Portfolio Management
Renaissance Technologies
Royce & Associates
Henderson Group
Robeco Investment Management
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners